Molecular epidemiology of sporadic (endemic) serogroup C meningococcal disease

Understanding the basis of sporadic (endemic) meningococcal disease may be critical to prevention of meningococcal epidemic outbreaks and to understanding fluctuations in incidence, Active, prospective, population-based surveillance and molecular epidemiologic techniques were used co study sporadic serogroup C meningococcal disease in a population of 2.34 million persons (Atlanta area), During 1988-1994, in which no outbreaks or case clusters were reported, 71 patients developed sporadic serogroup C meningococcal disease (annual incidence, 0.51/100,000), Eighty-three percent of patients were > 2 years old. By multilocus enzyme electrophoresis, pulsed-field gel electrophoresis, and serotyping, 84% (52/62) of the isolates available for study were identical or closely related members of the electrophoretic type 37 (ET 37) complex responsible for multiple serogroup C outbreaks in the United States in the 1990s, Sporadic disease caused by 9 clonal strains occurred over periods up to 4 years and accounted for 45% (28/62) of cases, Sporadic serogroup C meningococcal disease was most often due to a limited number of related strains that appear to slowly circulate in the population.